● Recruiting

Long-term Better Than Short-term ADT With Salvage RT

Condition: Prostate Cancer · Sponsor: Universitaire Ziekenhuizen KU Leuven

PhasePhase 2/Phase 3

Planned participants394

Who can joinMale, N/A to no upper limit

Healthy volunteersNo

About this study

A randomized, multicenter, prospective PHASE II trial to assess the effect of short- versus long-term adjuvant ADT with high dose salvage radiotherapy on distant metastasis free survival in case of biochemical relapse (BR) after radical prostatectomy.

This description comes directly from the study's public registry record.

Talk to the study team

Charlien Berghen, MD · 003216345217 · charlien.berghen@uzleuven.be

Gert De Meerleer, MD, PhD · 003216347600 · gert.demeerleer@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (3)

AZ Maria Middelares	Ghent, Belgium	Recruiting
UZ Gent	Ghent, Belgium	Recruiting
UZ Leuven	Leuven, Belgium	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04242017